Recent research highlights the critical role of elevated Lipoprotein(a), or Lp(a), in the development of cardiovascular disease. Lp(a) is a genetically determined lipid particle that contributes to atherosclerosis, thrombosis, and heart attack risk. Unlike conventional cholesterol, Lp(a) levels are largely unaffected by lifestyle or diet, making early detection and targeted intervention vital. Studies indicate that individuals with high Lp(a) levels have a significantly increased risk of coronary artery disease, stroke, and calcific aortic valve disease.